1-20 of 155
Craig H. Moskowitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Limited Duration Loncastuximab Tesirine Induces a High Rate of Complete Responses in Patients with Relapsed/Refractory Marginal Zone Lymphoma - Report of First Planned Interim Futility Analysis of a Multicenter Phase II Study

Izidore S. Lossos, Geoffrey Shouse, Alvaro J Alencar, Safia Sawleh, David S. Lessen, Craig H. Moskowitz, Jennifer Rose Chapman-Fredricks, Isildinha M. Reis, Russ Kuker, Juan Pablo Alderuccio
Journal: Blood
Blood (2024) 144 (Supplement 1): 3032.
https://doi.org/10.1182/blood-2024-200205
Published: 2024
Journal Articles

Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma

Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H. Schatz, Russ Kuker, David Sicre, Georgios Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Michele D. Stanchina, Asaad Trabolsi, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 337.
https://doi.org/10.1182/blood-2024-199093
Published: 2024
Journal Articles

Gene Expression-Based Classifier Reclassifies Burkitt Lymphoma, HGBL NOS, DLBCL NOS, and Double/Triple Hit Lymphomas into Subtypes with More Uniform Mutational and Microenvironment Landscapes and Treatment Response

Juan Pablo Alderuccio, Andrey Tyshevich, Daniel Cassidy, Catalina Amador, Ksenia Zornikova, Danil Ivanov, Laura Medina Andara, Dmitry Grachev, Asaad Trabolsi, Michele D. Stanchina, Alexander Nesmelov, Dan Morgenstern Kaplan, Konstantin Chernyshov, Nikita Kotlov, Craig H. Moskowitz, Alexander Bagaev, Krystle Nomie, Nathan H. Fowler, Jennifer Rose Chapman-Fredricks, Izidore S. Lossos
Journal: Blood
Blood (2024) 144 (Supplement 1): 2981.
https://doi.org/10.1182/blood-2024-200975
Published: 2024
Journal Articles

Epcoritamab with R-CHOP Overcomes Poor Risk Features of High Total Metabolic Tumor Volume in High-Risk Large B-Cell Lymphoma

Juan Pablo Alderuccio, Russ Kuker, Mark K Polar, Fei Yang, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1622.
https://doi.org/10.1182/blood-2024-209334
Published: 2024
Journal Articles

Sequential R-CHOP/(R)-ICE and Dose-Adjusted EPOCH-R Are Both Appropriate Frontline Treatments for Newly Diagnosed Primary Mediastinal B-Cell Lymphoma: Results of a Retrospective Analysis

Kurt S. Bantilan, Efrat Luttwak, Craig H. Moskowitz, Matthew Matasar, David J. Straus, Carol S. Portlock, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Steven Horwitz, Gilles Salles, Colette Owens, Pallawi Torka, Alexander P. Boardman, Kevin A. David, Zachary D. Epstein-Peterson, Anita Kumar, Philip Caron, Paola Ghione, Lorenzo Falchi, Jennifer K Lue, Raphael Steiner, Robert Stuver, Ahmet Dogan, Paul A. Hamlin, Andrew D. Zelenetz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4485.
https://doi.org/10.1182/blood-2024-205803
Published: 2024
Journal Articles

Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study

Alexandra Dreyfuss, Nivetha Ganesan, Alvaro J Alencar, Alexander P. Boardman, Philip Caron, Tiffany Chang, Theresa Davey, Kevin A. David, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Beatrice Fregonese, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Brandon S. Imber, Andrew M. Intlekofer, Derek Isrow, Erel Joffe, William T. Johnson, Anita Kumar, Michael Lariviere, Jennifer Kimberly Lue, Efrat Luttwak, Michael McNicholas, Zachary Moore, Brittney Munayirji, Ariela Noy, Colette Owens, Maria Lia Palomba, Jaldhi Patel, John P Plastaras, Alayna M. Santarosa, Heiko Schoder, Gunjan L. Shah, Raphael E. Steiner, Robert Stuver, Jakub Svoboda, Pallawi Torka, Santosha A. Vardhana, Andrew D. Zelenetz, Gilles Salles, Joachim Yahalom, Craig H. Moskowitz, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4434.
https://doi.org/10.1182/blood-2024-210689
Published: 2024
Journal Articles

Improved Outcomes for Primary Refractory Classical Hodgkin Lymphoma: A Retrospective Analysis

Alayna M. Santarosa, Nivetha Ganesan, Tiffany Chang, Kelly Hannigan, Ellie Casper, Gunjan L. Shah, Alexander P. Boardman, Philip Caron, Kevin A. David, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Ariel Krivisky, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Ariela Noy, Colette Owens, Maria Lia Palomba, Gilles Salles, Heiko Schoder, Raphael E. Steiner, Robert Stuver, Pallawi Torka, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Craig H. Moskowitz, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4429.
https://doi.org/10.1182/blood-2024-203857
Published: 2024
Journal Articles

Association of Body Composition Factors and Toxicity in Patients with Advanced Stage Hodgkin Lymphoma Receiving BV-AVD

Michele D. Stanchina, Russ Kuker, Sunwoo Han, Fei Yang, Mark K Polar, Jillian Lorayne Lykon, Tracy Crane, Melissa Lopez-Pentecost, Craig H. Moskowitz, Juan Pablo Alderuccio
Journal: Blood
Blood (2024) 144 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2024-203734
Published: 2024
Journal Articles

Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin

Alison Moskowitz, Gunjan L. Shah, Nivetha Ganesan, Tiffany Chang, Esther Drill, Theresa Davey, Helen Hancock, Brittney Munayirji, Monifa Douglas, Alayna M. Santarosa, Ellie Casper, Natasha Galasso, Sarima Subzwari, Marwah Jihad, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Ariela Noy, Colette Owens, Maria Lia Palomba, Gilles Salles, Raphael Steiner, Robert Stuver, Pallawi Torka, Santosha A. Vardhana, Andrew D. Zelenetz, Joachim Yahalom, Ahmet Dogan, Heiko Schoder, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 569.
https://doi.org/10.1182/blood-2024-202537
Published: 2024
Journal Articles

Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy

Matthew G. Mei, Gaetano Corazzelli, Frank Morschhauser, Elizabeth Phillips, Graham P. Collins, Hun Ju Lee, Steve M Ansell, Craig H. Moskowitz, Nathalie A. Johnson, John Kuruvilla, Martin Hutchings, María José Terol Castera, George Hawkins, Anna Vossenkaemper, Teresa Collins, Robin Lesley, Emma Dean, Ting Yu, Connor Hall, Virginie Cerec, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2023-180926
Published: 2023
Journal Articles

Limited Duration Loncastuximab Tesirine with Rituximab Induces High Complete Metabolic Response Rate in High-Risk Relapsed/Refractory Follicular Lymphoma - a Phase 2 Study

Juan Pablo Alderuccio, Alvaro J. Alencar, Jonathan H. Schatz, Russ Kuker, Georgio Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Nathalie Padron, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 984.
https://doi.org/10.1182/blood-2023-178825
Published: 2023
Journal Articles

Distinct Patterns of CD4+ and CD8+ T-Cell Clonal Expansion Enable Broad Clinical Responses to Pembrolizumab + GVD in Patients with Relapsed Hodgkin Lymphoma

Beatriz Wills, Jahan Rahman, Nivetha Ganesan, Gunjan L. Shah, Ariela Noy, Heiko Schoder, Joachim Yahalom, Anita Kumar, Lorenzo Falchi, Paul A. Hamlin, Maria Lia Palomba, William Johnson, Andrew M. Intlekofer, Philip Caron, Theresa Davey, Helen Hancock, Natasha Galasso, Brittney Munayirji, Ya Hui Lin, Alayna Santarosa, Ellie Casper, Georgio Pongas, Andrew D. Zelenetz, Craig H. Moskowitz, Gilles Salles, Santosha A Vardhana, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1623.
https://doi.org/10.1182/blood-2023-185083
Published: 2023
Journal Articles

Predictors and Timing of Venous Thromboembolism in Lymphoma

Asaad Trabolsi, Thomas Plate, IV, Rachel S. Kronenfeld, Leticia E. Campoverde, Dan Morgenstern Kaplan, Alyssa Mercadel, Michael Caballero, Wei Zhao, Izidore S. Lossos, Craig H. Moskowitz, Gerald A. Soff
Journal: Blood
Blood (2023) 142 (Supplement 1): 2642.
https://doi.org/10.1182/blood-2023-173903
Published: 2023
Journal Articles

PET/CT Enables Appropriate Staging in Extranodal Marginal Zone Lymphoma

Juan Pablo Alderuccio, Michele D. Stanchina, Jean L. Koff, Isildinha M. Reis, Eduardo Edelman Saul, Melissa C. Larson, Dai Chihara, Wei Zhao, Thomas M. Habermann, Peter Martin, Loretta J. Nastoupil, Jennifer R. Chapman-Fredricks, Andrew L. Feldman, Brian K. Link, Brad S. Kahl, Jonathon B. Cohen, Mark K Polar, Rafael Henneman Sassi, Craig H. Moskowitz, Jonathan W. Friedberg, James R. Cerhan, Russ Kuker, Christopher R. Flowers, Izidore S. Lossos
Journal: Blood
Blood (2023) 142 (Supplement 1): 5134.
https://doi.org/10.1182/blood-2023-179478
Published: 2023
Journal Articles

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

Clinical Trials & Observations
Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Alex F. Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H. Moskowitz
Journal: Blood
Blood (2023) 142 (10): 878–886.
https://doi.org/10.1182/blood.2022019386
Published: 2023
Includes: Supplemental data
Journal Articles

Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Beatriz Wills, Nivetha Ganesan, Gunjan L. Shah, Phillip Wong, Kimon V. Argyropoulos, Filiz Sen, Ahmet Dogan, David J. Straus, Ariela Noy, Anita Kumar, Heiko Schoder, Laure Michaud, Maria Lia Palomba, Lorenzo Falchi, Oscar B Lahoud, Paul A. Hamlin, Joachim Yahalom, William T. Johnson, Andrew D. Zelenetz, Andrew M. Intlekofer, Colette Owens, Connie Lee Batlevi, Audrey Hamilton, Philip C Caron, Steven M. Horwitz, Natasha Galasso, Helen Hancock, Theresa Davey, Alayna Santarosa, Leslie Perez, Charisse Capadona, Brittney Munayirji, Matthew J. Matasar, Georgios Pongas, Ellie Casper, Gilles Salles, Craig H. Moskowitz, Santosha Vardhana, Alison J. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 9286–9288.
https://doi.org/10.1182/blood-2022-160206
Published: 2022
Journal Articles

Calculation of Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma Using a Deep Learning-Aided Automated Method

Juan Pablo Alderuccio, Russ A. Kuker, David Lehmkuhl, Deukwoo Kwon, Andrea Cordoba, Weizhao Zhao, Izidore S. Lossos, Craig H. Moskowitz, Fei Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 4972–4973.
https://doi.org/10.1182/blood-2022-165676
Published: 2022
Journal Articles

Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2

Robert Stuver, Laure Michaud, Carla Casulo, Ranjana H. Advani, Elizabeth L. Budde, Paul M. Barr, Connie Lee Batlevi, Philip C Caron, Louis S. Constine, Savita Dandapani, Pamela Drullinsky, Jonathan W. Friedberg, Clare Grieve, Audrey Hamilton, Paul A. Hamlin, Richard Hoppe, Steven M. Horwitz, Niloufer Khan, Matthew J. Matasar, Ariela Noy, M.Lia Palomba, Heiko Schoder, David J. Straus, Shreya Vemuri, Joachim Yahalom, Joanna C. Yang, Anas Younes, Andrew D. Zelenetz, Craig H. Moskowitz, Anita Kumar, Alison J. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 1756–1758.
https://doi.org/10.1182/blood-2022-156382
Published: 2022
Journal Articles

Metabolic Tumor Volume Predicts Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Loncastuximab Tesirine in the Lotis-2 Trial

Juan Pablo Alderuccio, Russ A Kuker, Isildinha M Reis, Muthiah Nachiappan, Brad S. Kahl, Mehdi Hamadani, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Brian T. Hess, Matthew A. Lunning, Pier Luigi Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Eric Yu, Paolo F Caimi, Deukwoo Kwon, Izidore S. Lossos, Fei Yang, Craig H. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 6650–6652.
https://doi.org/10.1182/blood-2022-162758
Published: 2022
Journal Articles

Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Large Multi-Trial Analysis Based on Individual Patient Data

Julia Driessen, Fer de Wit, Alex F. Herrera, Pier Luigi Luigi Zinzani, Ann S. LaCasce, Craig H. Moskowitz, Ramon Garcia-Sanz, Peter D. Cole, Michael Fuchs, Horst Mueller, Peter Borchmann, Heiko Schöder, Josée M Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Journal: Blood
Blood (2021) 138 (Supplement 1): 879.
https://doi.org/10.1182/blood-2021-147810
Published: 2021